Latency II is defined by expression of EBNA1, LMP1, and LMP2A/B and is most closely associated with Hodgkin lymphoma, NPC, and T/NK cell lymphomas (31–34). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.